KFS
PACB icon

Kelly Financial Services’s Pacific Biosciences PACB Stock Holding History

Kelly Financial Services’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-75
Closed -$1.95K – 655
2020
Q4 		$1.95K Buy
+75
New +$1.27K ﹤0.01% 463

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
SM
SB Management Abu Dhabi, United Arab Emirates $516M AUM 40.71% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Kelly Financial Services's PACB Position: Q1 2021 in Review

Kelly Financial Services sold out of Pacific Biosciences (PACB) in Q1 2021, closing a stake of 75 shares — an estimated $1.95K sold.

Kelly Financial Services first reported a position in PACB in Q4 2020 and held it in 1 quarter. The position peaked at $1.95K in Q4 2020. 263 funds tracked by Wall St. Rank hold PACB as of Q1 2021.

  • Kelly Financial Services reported no remaining Pacific Biosciences position as of Q1 2021 after selling out during the quarter.
  • Kelly Financial Services sold 75 Pacific Biosciences shares in Q1 2021, an estimated $1.95K.
  • Kelly Financial Services first reported a position in Pacific Biosciences in Q4 2020 and held it in 1 quarter.
  • Kelly Financial Services's Pacific Biosciences position peaked at $1.95K in Q4 2020.
  • 263 funds tracked by Wall St. Rank held Pacific Biosciences as of Q1 2021.

Based on Kelly Financial Services's 13F filing for Q1 2021, filed 17 Jul 2024.